Cargando…
The New Era of Systemic Treatment for Hepatocellular Carcinoma: From the First Line to the Optimal Sequence
Hepatocellular carcinoma (HCC) represents the most common primary liver cancer and is considered a major global health problem as one of the leading causes of cancer-related death in the world. Due to the increase in life expectancy and the epidemiological growth of specific risk factors, such as me...
Autores principales: | Cerreto, Maria, Cardone, Ferdinando, Cerrito, Lucia, Stella, Leonardo, Santopaolo, Francesco, Pallozzi, Maria, Gasbarrini, Antonio, Ponziani, Francesca Romana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605429/ https://www.ncbi.nlm.nih.gov/pubmed/37887533 http://dx.doi.org/10.3390/curroncol30100633 |
Ejemplares similares
-
Microvascular Thrombosis and Liver Fibrosis Progression: Mechanisms and Clinical Applications
por: Airola, Carlo, et al.
Publicado: (2023) -
Bariatric Surgery and Liver Disease: General Considerations and Role of the Gut–Liver Axis
por: Cerreto, Maria, et al.
Publicado: (2021) -
Molecular Mechanisms Underlying Vascular Liver Diseases: Focus on Thrombosis
por: Giuli, Lucia, et al.
Publicado: (2023) -
Non-Invasive Biomarkers for Immunotherapy in Patients with Hepatocellular Carcinoma: Current Knowledge and Future Perspectives
por: Pallozzi, Maria, et al.
Publicado: (2022) -
Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment
por: Stella, Leonardo, et al.
Publicado: (2022)